Diagnosed oral cavity and salivary gland disorders and the risk of incident Parkinson disease, Alzheimer disease, dementia and all-cause mortality: a retrospective cohort study.
Diagnosed oral cavity and salivary gland disorders and the risk of incident Parkinson disease, Alzheimer disease, dementia and all-cause mortality: a retrospective cohort study.
Where did the research take place?
The study site has not been established. Author addresses may differ from where the research occurred.
Lahore, PK · Author affiliation
Department of Medicine King Edward Medical University Lahore PakistanLocation evidence
Galveston, US · Author affiliation
Department of Cardiovascular Medicine The University of Texas Medical Branch Galveston Texas USALocation evidence
Multan, PK · Author affiliation
Department of Medicine Nishtar Medical University Multan PakistanLocation evidence
Sialkot, PK · Author affiliation
Department of Medicine Khawaja Muhammad Safdar Medical College Sialkot PakistanLocation evidence
Kabul, AF · Author affiliation
Department of Medicine Kabul University of Medical Sciences Kabul AfghanistanLocation evidence
Memphis, US · Author affiliation
Department of Medicine The University of Tennessee Health Science Center Memphis Tennessee USALocation evidence
US · Author affiliation · country only
Department of Medicine University of Louisville School of Medicine Louisville Kentucky USALocation evidence
A plain-language reading has not been prepared for this paper yet.
Original abstract
BACKGROUND: Oral diseases encompass a heterogeneous group of conditions affecting the oral cavity and associated structures. Certain chronic inflammatory oral diseases, particularly periodontitis, have been linked to systemic inflammation and may contribute to neurodegenerative processes. However, long-term evidence on their association with Parkinson's disease (PD), Alzheimer's disease (AD), dementia and mortality remains inconsistent. This study aims to investigate whether diagnosed oral cavity and salivary gland disorders are associated with long‑term risk of PD, AD, dementia and all-cause mortality in older adults. AIMS: To investigate whether diagnosed oral cavity and salivary gland disorders are associated with long-term risk of Parkinson disease, Alzheimer disease, dementia, and all-cause mortality in older adults. METHODS: This retrospective propensity score-matched cohort study utilised the TriNetX US Collaborative Network. Patients aged ≥60 years with a documented diagnosis of diseases of the oral cavity and salivary glands (ICD-10-CM K00-K14) were 1:1 matched with patients without oral diseases on demographics, comorbidities and medication use (n = 232 809 per group after matching). The index date was the first documented oral disease diagnosis (exposure cohort) or equivalent healthcare encounter (control cohort). New-onset PD, AD, any-type dementia and all-cause mortality were assessed at 5- and 13-year follow-up using risk ratios (RRs), hazard ratios (HRs) and Kaplan-Meier survival analysis. RESULTS: At 5 years, diagnosis of oral cavity and salivary gland diseases was associated with significantly increased risk of new-onset PD (HR 1.212, 95% confidence interval (CI) 1.133-1.296), any dementia (HR 1.132, 95% CI 1.098-1.167) and all-cause mortality (HR 1.117, 95% CI 1.101-1.134). AD risk was modestly elevated (HR 1.100, 95% CI 1.033-1.171). At 13 years, the increased risk persisted for PD (HR 1.146), dementia (HR 1.060) and mortality (HR 1.113), but the association with AD was no longer significant (HR 0.998, 95% CI 0.959-1.038). CONCLUSIONS: Diagnosed oral cavity and salivary gland diseases are independently associated with sustained long-term risk of PD, dementia and all-cause mortality, but the association with AD appears time-limited. These findings highlight oral health as a potentially modifiable factor in neurodegenerative disease prevention and support multidisciplinary approaches to oral care in older adults.